CIK: 1424630 - Address: C/o Aveo Pharmaceuticals, Inc., 30 Winter Street, Boston, MA 02108
4 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret112257-20-16-32-9
S%wins50050505010050

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

10/26/16 16:30
10/25/16
ADXSAdvaxis, Inc.DEHealthDrugPharmaceutical PreparationsMayes, Gregory T.NJDOChief BuS-1588.239-19-16103D152-2441-22-29-5-9-451664
10/27/15 16:30
10/26/15
ADXSAdvaxis, Inc.DEHealthDrugPharmaceutical PreparationsMayes, Gregory T.NJOCOOS-22411.6315-19-14120D226233-43-37-43821474-2-46-35-32
12/22/11 16:46
12/21/11
UGNEUnigene Laboratories IncDEHealthMdCmMedicinal Chemicals & BotanicMayes, Gregory T.NJOVP,Corp P10.525002New2D
2/20/08 16:25
2/15/08
IMCLImclone Systems IncDEHealthBioPrdBiological Products, (No DiagMayes, Gregory T.NJOVP,InterM.d00.00011D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact